Nitai Pada Bhattacharyya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nitai Pada Bhattacharyya has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Swasti Raychaudhuri
CSIR-Centre for Cellular and Molecular Biology
5 shared publications- Srijit Das
Crystallography & Molecular Biology Division, Saha Institute of Nuclear Physics, 1/AF Bidhannagar, Kolkata 700064, India
4 shared publications - Chinmay Saha
Department of Endocrinology and Metabolism Institute of Post Graduate Medical Education & Research and Seth Sukhlal Karnani Memorial Hospital Kolkata India
3 shared publications Debashis Mukhopadhyay
Biophysics and Structural Genomics Division, Saha Institute of Nuclear Physics, 1/AF, Bidhan Nagar, Kolkata, 700 064, India
3 shared publicationsJayeeta Ghose
The Ohio State University
3 shared publications- Kamalika Roy Choudhury
ICMR-Laboratory, ICMR-NICED, P-33, C.I.T. Road, Scheme XM, Beliaghata, Kolkata, West Bengal 700010, India
3 shared publications
Latest Publications
- Open Access
- 6 August 2025
- Published by MDPI AG in Preprints.org
Integrated Molecular and Clinical Profiling of Primary Mitochondrial Oxidative Phosphorylation Disorders in an Indian Cohort: Insights from Genetics, Neuroimaging, and Machine Learning
Mitochondrial disorders are a diverse group of inherited diseases caused by defects in oxidative phosphorylation, the primary way cells produce energy. These disorders often affect multiple organ systems, particularly those with high energy demands, such as the brain, muscles, and heart. Although increasingly recognized worldwide, mitochondrial diseases are still underdiagnosed in resource-limited areas. This prospective observational study aimed to describe the clinical, biochemical, imaging, electrophysiological, and genetic features of 48 patients suspected of having mitochondrial disease at a tertiary care center in Eastern India. Participants were classified into four main clinical syndromes: mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes; Leber hereditary optic neuropathy; Leigh syndrome; and chronic progressive external ophthalmoplegia. The average age was 20.4 years (standard deviation 12.3; range 5–60), with a slight male predominance. Molecular testing confirmed known pathogenic mutations in mitochondrial transfer RNA genes, mitochondrial respiratory complex genes, and ATP synthase subunits, depending on the syndrome. Patients exhibited characteristic abnormalities on brain imaging, including stroke-like lesions in the temporal and parietal lobes or symmetrical involvement of the basal ganglia. Biochemical tests revealed elevated lactate levels in blood and cerebrospinal fluid. Electroencephalography often showed slowing or epileptiform discharges in those with brain involvement. Machine learning techniques helped identify clinical patterns, demonstrating their potential to aid in diagnosis. We offer one of the most comprehensive overviews of mitochondrial diseases in South Asia to date, highlighting the need for accessible molecular diagnostics and the usefulness of computational tools in understanding complex disease phenotypes.
- 6 August 2025
- Published by MDPI AG in Preprints.org
Open AccessIntegrated Molecular and Clinical Profiling of Primary Mitochondrial Oxidative Phosphorylation Disorders in an Indian Cohort: Insights from Genetics, Neuroimaging, and Machine Learning
Mitochondrial disorders are a diverse group of inherited diseases caused by defects in oxidative phosphorylation, the primary way cells produce energy. These disorders often affect multiple organ systems, particularly those with high energy demands, such as the brain, muscles, and heart. Although increasingly recognized worldwide, mitochondrial diseases are still underdiagnosed in resource-limited areas. This prospective observational study aimed to describe the clinical, biochemical, imaging, electrophysiological, and genetic features of 48 patients suspected of having mitochondrial disease at a tertiary care center in Eastern India. Participants were classified into four main clinical syndromes: mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes; Leber hereditary optic neuropathy; Leigh syndrome; and chronic progressive external ophthalmoplegia. The average age was 20.4 years (standard deviation 12.3; range 5–60), with a slight male predominance. Molecular testing confirmed known pathogenic mutations in mitochondrial transfer RNA genes, mitochondrial respiratory complex genes, and ATP synthase subunits, depending on the syndrome. Patients exhibited characteristic abnormalities on brain imaging, including stroke-like lesions in the temporal and parietal lobes or symmetrical involvement of the basal ganglia. Biochemical tests revealed elevated lactate levels in blood and cerebrospinal fluid. Electroencephalography often showed slowing or epileptiform discharges in those with brain involvement. Machine learning techniques helped identify clinical patterns, demonstrating their potential to aid in diagnosis. We offer one of the most comprehensive overviews of mitochondrial diseases in South Asia to date, highlighting the need for accessible molecular diagnostics and the usefulness of computational tools in understanding complex disease phenotypes.
- Open Access
LncRNAOmics: A Comprehensive Review of Long Non-Coding RNAs in Plants
The large portion of the eukaryotic genomes was considered non-functional and called the “dark matter” of the genome, now appearing as regulatory hubs coding for RNAs without the potential for making proteins, known as non-coding RNA. Long non-coding RNA (lncRNA) is defined as functional RNA molecules having lengths larger than 200 nucleotides without the potential for coding for proteins. Thousands of lncRNAs are identified in different plants and animals. LncRNAs are characterized by a low abundance, fewer exons than mRNA, tissue-specific expression, and low sequence conservation compared to protein-coding genes (PCGs). LncRNAs, like PCGs, are regulated by promoters and enhancers with characteristic chromatin signatures, DNA methylation, multiple exons, introns, and alternate splicing. LncRNAs interact with DNA, mRNA, microRNA, and proteins, including chromatin/histone modifiers, transcription factors/repressors, epigenetic regulators, spliceosomal, and RNA-binding proteins. Recent observations indicate that lncRNAs code for small peptides, also called micropeptides (<100 amino acids), and are involved in the development and growth of plants, suggesting the bi-functional activities of lncRNAs. LncRNAs have emerged as the major regulators of diverse functions, principally by altering the transcription of target genes. LncRNAs are involved in plant growth, development, immune responses, and various physiological processes. Abiotic, biotic, nutrient, and other environmental stresses alter the expressions of numerous lncRNAs. Understanding the mechanisms of actions of lncRNAs opens up the possibility of improving agronomic traits by manipulating lncRNAs. However, further studies are required in order to find the interactions among the deregulated lncRNAs and validate the findings from high-throughput studies to harness their potential in crop improvement.
Open AccessLncRNAOmics: A Comprehensive Review of Long Non-Coding RNAs in Plants
The large portion of the eukaryotic genomes was considered non-functional and called the “dark matter” of the genome, now appearing as regulatory hubs coding for RNAs without the potential for making proteins, known as non-coding RNA. Long non-coding RNA (lncRNA) is defined as functional RNA molecules having lengths larger than 200 nucleotides without the potential for coding for proteins. Thousands of lncRNAs are identified in different plants and animals. LncRNAs are characterized by a low abundance, fewer exons than mRNA, tissue-specific expression, and low sequence conservation compared to protein-coding genes (PCGs). LncRNAs, like PCGs, are regulated by promoters and enhancers with characteristic chromatin signatures, DNA methylation, multiple exons, introns, and alternate splicing. LncRNAs interact with DNA, mRNA, microRNA, and proteins, including chromatin/histone modifiers, transcription factors/repressors, epigenetic regulators, spliceosomal, and RNA-binding proteins. Recent observations indicate that lncRNAs code for small peptides, also called micropeptides (<100 amino acids), and are involved in the development and growth of plants, suggesting the bi-functional activities of lncRNAs. LncRNAs have emerged as the major regulators of diverse functions, principally by altering the transcription of target genes. LncRNAs are involved in plant growth, development, immune responses, and various physiological processes. Abiotic, biotic, nutrient, and other environmental stresses alter the expressions of numerous lncRNAs. Understanding the mechanisms of actions of lncRNAs opens up the possibility of improving agronomic traits by manipulating lncRNAs. However, further studies are required in order to find the interactions among the deregulated lncRNAs and validate the findings from high-throughput studies to harness their potential in crop improvement.
- Open Access
- 28 May 2025
- Published by MDPI AG in Preprints.org
LncRNAOmics: A Comprehensive Review of Long Non-Coding RNAs in Plants
The large portion of the eukaryotic genomes was considered non-functional and called the “dark matter” of the genome, now appearing as regulatory hubs coding for RNAs without potential for making proteins, known as non-coding RNA. Long non-coding RNA (lncRNA) is defined as functional RNA molecules having lengths larger than 200 nucleotides without the potential of coding for proteins. Thousands of lncRNAs are identified in different plants and animals. LncRNAs are characterized by low abundance, fewer exons than mRNA, exhibit tissue-specific expression, and low sequence conservation compared to protein-coding genes (PCGs). LncRNAs, like PCGs, are regulated by promoters and enhancers with characteristic chromatin signatures, DNA methylation, multiple exons, introns, and alternate splicing. LncRNAs interact with DNA, mRNA, microRNA, and proteins, including chromatin/histone modifiers, transcription factors/repressors, epigenetic regulators, spliceosomal, and RNA-binding proteins. Recent observations indicate that lncRNAs code for small peptides, also called micropeptides (< 100 amino acids), and are involved in development and growth of plants, suggesting bi-functional activities of lncRNAs. LncRNAs have emerged as the major regulators of diverse functions, principally by altering the transcription of target genes. LncRNAs are involved in plant growth, development, immune responses, and various physiological processes. Abiotic, biotic, nutrient, and other environmental stresses alter the expressions of numerous lncRNAs. Understanding the mechanisms of actions of lncRNAs opens up the possibility of improving agronomic traits by manipulating lncRNAs. However, further studies are required to find the interactions among the deregulated lncRNAs and validate the findings from high throughput studies to harness their potential in crop improvement.
- 28 May 2025
- Published by MDPI AG in Preprints.org
Open AccessLncRNAOmics: A Comprehensive Review of Long Non-Coding RNAs in Plants
The large portion of the eukaryotic genomes was considered non-functional and called the “dark matter” of the genome, now appearing as regulatory hubs coding for RNAs without potential for making proteins, known as non-coding RNA. Long non-coding RNA (lncRNA) is defined as functional RNA molecules having lengths larger than 200 nucleotides without the potential of coding for proteins. Thousands of lncRNAs are identified in different plants and animals. LncRNAs are characterized by low abundance, fewer exons than mRNA, exhibit tissue-specific expression, and low sequence conservation compared to protein-coding genes (PCGs). LncRNAs, like PCGs, are regulated by promoters and enhancers with characteristic chromatin signatures, DNA methylation, multiple exons, introns, and alternate splicing. LncRNAs interact with DNA, mRNA, microRNA, and proteins, including chromatin/histone modifiers, transcription factors/repressors, epigenetic regulators, spliceosomal, and RNA-binding proteins. Recent observations indicate that lncRNAs code for small peptides, also called micropeptides (< 100 amino acids), and are involved in development and growth of plants, suggesting bi-functional activities of lncRNAs. LncRNAs have emerged as the major regulators of diverse functions, principally by altering the transcription of target genes. LncRNAs are involved in plant growth, development, immune responses, and various physiological processes. Abiotic, biotic, nutrient, and other environmental stresses alter the expressions of numerous lncRNAs. Understanding the mechanisms of actions of lncRNAs opens up the possibility of improving agronomic traits by manipulating lncRNAs. However, further studies are required to find the interactions among the deregulated lncRNAs and validate the findings from high throughput studies to harness their potential in crop improvement.
- Open Access
- 1 September 2016
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 7, 188-194
Trans -activation of small EDRK-rich factor 2 ( SERF2 ) promoter by Heat Shock Factor 1
- 1 September 2016
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 7, 188-194
Open AccessTrans -activation of small EDRK-rich factor 2 ( SERF2 ) promoter by Heat Shock Factor 1
- Open Access
- 1 August 2016
- Published by Springer Nature in BMC Systems Biology
- Vol. 10 (S2) , 197-213
Wnt signal transduction pathways: modules, development and evolution
Wnt signal transduction pathway (Wnt STP) is a crucial intracellular pathway mainly due to its participation in important biological processes, functions, and diseases, i.e., embryonic development, stem-cell management, and human cancers among others. This is why Wnt STP is one of the highest researched signal transduction pathways. Study and analysis of its origin, expansion and gradual development to the present state as found in humans is one aspect of Wnt research. The pattern of development and evolution of the Wnt STP among various species is not clear till date. A phylogenetic tree created from Wnt STPs of multiple species may address this issue. In this respect, we construct a phylogenetic tree from modules of Wnt STPs of diverse species. We term it as the ‘Module Tree’. A module is nothing but a self-sufficient minimally-dependent subset of the original Wnt STP. Authenticity of the module tree is tested by comparing it with the two reference trees. The module tree performs better than an alternative phylogenetic tree constructed from pathway topology of Wnt STPs. Moreover, an evolutionary emergence pattern of the Wnt gene family is created and the module tree is tallied with it to showcase the significant resemblances.
- 1 August 2016
- Published by Springer Nature in BMC Systems Biology
- Vol. 10 (S2) , 197-213
Open AccessWnt signal transduction pathways: modules, development and evolution
Wnt signal transduction pathway (Wnt STP) is a crucial intracellular pathway mainly due to its participation in important biological processes, functions, and diseases, i.e., embryonic development, stem-cell management, and human cancers among others. This is why Wnt STP is one of the highest researched signal transduction pathways. Study and analysis of its origin, expansion and gradual development to the present state as found in humans is one aspect of Wnt research. The pattern of development and evolution of the Wnt STP among various species is not clear till date. A phylogenetic tree created from Wnt STPs of multiple species may address this issue. In this respect, we construct a phylogenetic tree from modules of Wnt STPs of diverse species. We term it as the ‘Module Tree’. A module is nothing but a self-sufficient minimally-dependent subset of the original Wnt STP. Authenticity of the module tree is tested by comparing it with the two reference trees. The module tree performs better than an alternative phylogenetic tree constructed from pathway topology of Wnt STPs. Moreover, an evolutionary emergence pattern of the Wnt gene family is created and the module tree is tallied with it to showcase the significant resemblances.
- 1 May 2016
- Published by Elsevier in Experimental Cell Research
- Vol. 343 (2) , 107-117
Huntingtin interacting protein HYPK is a negative regulator of heat shock response and is downregulated in models of Huntington's Disease
- 1 May 2016
- Published by Elsevier in Experimental Cell Research
- Vol. 343 (2) , 107-117
Huntingtin interacting protein HYPK is a negative regulator of heat shock response and is downregulated in models of Huntington's Disease
- 1 January 2016
- Published by Bentham Science Publishers Ltd. in MicroRNA
- Vol. 4 (3) , 185-193
Heat Shock Factor 1-Regulated miRNAs Can Target Huntingtin and Suppress Aggregates of Mutant Huntingtin
Heat shock factor 1 (HSF1) is the master regulator of chaperone network in mammalian cells and can protect cells from adverse effects of misfolded proteins by rapidly inducing expression of multiple heat shock proteins (HSPs) and other cytoprotective proteins. We have earlier reported that HSF1 can also regulate transcription of microRNAs (miRNAs) in heat shock-dependent manner and these miRNAs are likely to regulate diverse cellular processes by acting as downstream effectors of HSF1. In the present study we show that HSF1-regulated miRNAs can target huntingtin whose mutation causes Huntington’s Disease (HD), in HD cell model. HSF1-regulated miRNAs can also suppress aggregates of mutant huntingtin indicating their potential as therapeutic agents for the treatment of HD. Our study indicates that the protective effect of HSF1 in the context of HD is a consequence of synergistic induction of heat shock proteins and HSF1-regulated huntingtin-targeting miRNAs.
- 1 January 2016
- Published by Bentham Science Publishers Ltd. in MicroRNA
- Vol. 4 (3) , 185-193
Heat Shock Factor 1-Regulated miRNAs Can Target Huntingtin and Suppress Aggregates of Mutant Huntingtin
Heat shock factor 1 (HSF1) is the master regulator of chaperone network in mammalian cells and can protect cells from adverse effects of misfolded proteins by rapidly inducing expression of multiple heat shock proteins (HSPs) and other cytoprotective proteins. We have earlier reported that HSF1 can also regulate transcription of microRNAs (miRNAs) in heat shock-dependent manner and these miRNAs are likely to regulate diverse cellular processes by acting as downstream effectors of HSF1. In the present study we show that HSF1-regulated miRNAs can target huntingtin whose mutation causes Huntington’s Disease (HD), in HD cell model. HSF1-regulated miRNAs can also suppress aggregates of mutant huntingtin indicating their potential as therapeutic agents for the treatment of HD. Our study indicates that the protective effect of HSF1 in the context of HD is a consequence of synergistic induction of heat shock proteins and HSF1-regulated huntingtin-targeting miRNAs.
- 1 January 2016
- Published by Elsevier in Journal of Proteomics
- Vol. 132, 155-166
Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology
- 1 January 2016
- Published by Elsevier in Journal of Proteomics
- Vol. 132, 155-166
Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology
- 7 October 2015
- Published by Bentham Science Publishers Ltd. in MicroRNA
- Vol. 4 (2) , 86-100
Delayed Cell Cycle Progression in STHdhQ111/HdhQ111 Cells, a Cell Model for Huntington’s Disease Mediated by microRNA-19a, microRNA-146a and microRNA-432
Several indirect evidences are available to indicate that abnormalities in cell cycle may contribute to pathogenesis of Huntington’s disease (HD). Here, we show that the cell cycle progression in STsdhQ111/HdhQ111cells, a cell model of HD, is delayed in S and G2-M phases compared to control STHdhQ7/HdhQ7cells. Expression of 17 genes, like PCNA and CHEK1, was increased in STHdhQ111/HdhQ111cells. Increased expressions of PCNA, CHEK1 and CCNA2, and an enhanced phosphorylation of Rb1 were observed in primary cortical neurons expressing mutant N-terminal huntingtin (HTT), R6/2 mice and STHdhQ111/HdhQ111 cells. This increase in the expressions of PCNA, CHEK1 and CCNA2 was found to be the result of decreased expressions of miR-432, miR-146a, and (miR-19a and miR-146a), respectively. Enhanced apoptosis was observed at late S phase and G2-M phase in STHdhQ111/HdhQ111cells. Exogenous expressions of these miRNAs in STHdhQ111/HdhQ111 cells rescued the abnormalities in cell cycle and apoptosis. We also observed that inhibitors of cell cycle could decrease cell death in a cell model of HD. Based on these results obtained in cell and animal model of HD, we propose that inhibition of cell cycle either by miRNA expressions or by using inhibitors could be a potential approach for the treatment of HD.
- 7 October 2015
- Published by Bentham Science Publishers Ltd. in MicroRNA
- Vol. 4 (2) , 86-100
Delayed Cell Cycle Progression in STHdhQ111/HdhQ111 Cells, a Cell Model for Huntington’s Disease Mediated by microRNA-19a, microRNA-146a and microRNA-432
Several indirect evidences are available to indicate that abnormalities in cell cycle may contribute to pathogenesis of Huntington’s disease (HD). Here, we show that the cell cycle progression in STsdhQ111/HdhQ111cells, a cell model of HD, is delayed in S and G2-M phases compared to control STHdhQ7/HdhQ7cells. Expression of 17 genes, like PCNA and CHEK1, was increased in STHdhQ111/HdhQ111cells. Increased expressions of PCNA, CHEK1 and CCNA2, and an enhanced phosphorylation of Rb1 were observed in primary cortical neurons expressing mutant N-terminal huntingtin (HTT), R6/2 mice and STHdhQ111/HdhQ111 cells. This increase in the expressions of PCNA, CHEK1 and CCNA2 was found to be the result of decreased expressions of miR-432, miR-146a, and (miR-19a and miR-146a), respectively. Enhanced apoptosis was observed at late S phase and G2-M phase in STHdhQ111/HdhQ111cells. Exogenous expressions of these miRNAs in STHdhQ111/HdhQ111 cells rescued the abnormalities in cell cycle and apoptosis. We also observed that inhibitors of cell cycle could decrease cell death in a cell model of HD. Based on these results obtained in cell and animal model of HD, we propose that inhibition of cell cycle either by miRNA expressions or by using inhibitors could be a potential approach for the treatment of HD.